Search for: "MORGAN COMPANY" Results 601 - 620 of 5,202
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jan 2024, 10:00 pm
Morgan Healthcare Conference has passed, we are turning to what funding the market managed to raise last year and what may be on the horizon. [read post]
24 Nov 2020, 10:00 pm
Morgan Lewis partner Sean Donahue, of counsel Jeffrey Letalien, and associate Brian Soares authored an INSIGHTS: The Corporate & Securities Law Advisor article about the corporate and securities law issues that must be considered when undertaking special purpose acquisition company (SPAC) transactions. [read post]
2 Jun 2020, 10:00 pm
Morgan Lewis partner Kurt Mayr and of counsel David Lawton authored a Law360 article about alternatives for companies that lack sufficient liquidity (from revenues or debt) to afford a lengthy—or expedited—bankruptcy process. [read post]
6 Apr 2022, 10:00 pm
Morgan Lewis partners Jocelyn Cuttino, Sharon Masling, and Louise Skinner authored an article for International Employment Lawyer on how employers are actively seeking to increase diversity, equity, and inclusion initiatives at their companies without running afoul of global, federal, and state anti-discrimination statutes. [read post]
20 Apr 2022, 10:00 pm
Luxury Daily  published a column by Morgan Lewis partner Leni Battaglia and associate Carolyn Corcoran discussing the pending New York Fashion Workers Act and what the implications of the bill could mean in terms of compliance requirements on model and creative management companies. [read post]
23 Mar 2020, 3:00 am by John Jenkins
  Anyway, this Morgan Lewis memo says that now might be a good time to think about […] [read post]
26 Aug 2020, 10:00 pm
In this opinion piece Bruce discussed how the reforms will affect UK company financings. [read post]
26 Jul 2020, 10:00 pm
Morgan Lewis FDA, litigation, and healthcare lawyers authored a LawFlash outlining key issues that companies marketing products and services for coronavirus (COVID-19) should be aware of, including healthcare, FDA, clinical laboratory, product liability, and digital and telehealth laws and regulations. [read post]
24 Nov 2020, 10:00 pm
Morgan Lewis partner Sean Donahue, of counsel Jeffrey Letalien, and associate Brian Soares authored an INSIGHTS: The Corporate & Securities Law Advisor article about the corporate and securities law issues that must be considered when undertaking special purpose acquisition company (SPAC) transactions. [read post]
26 Jul 2020, 10:00 pm
Morgan Lewis FDA, litigation, and healthcare lawyers authored a LawFlash outlining key issues that companies marketing products and services for coronavirus (COVID-19) should be aware of, including healthcare, FDA, clinical laboratory, product liability, and digital and telehealth laws and regulations. [read post]
24 Nov 2020, 10:00 pm
Morgan Lewis partner Sean Donahue, of counsel Jeffrey Letalien, and associate Brian Soares authored an INSIGHTS: The Corporate & Securities Law Advisor article about the corporate and securities law issues that must be considered when undertaking special purpose acquisition company (SPAC) transactions. [read post]
8 Sep 2020, 10:00 pm
Welcome to Morgan Lewis’s Takeover Monitor Germany. [read post]
2 Jun 2020, 10:00 pm
Morgan Lewis partner Kurt Mayr and of counsel David Lawton authored a Law360 article about alternatives for companies that lack sufficient liquidity (from revenues or debt) to afford a lengthy—or expedited—bankruptcy process. [read post]
21 Jul 2016, 3:10 pm by Marcia Narine
Jamie Dimon (JP Morgan Chase), Warren Buffet (Berkshire Hathaway), Mary Barra (General Motors), Jeff Immet (GE), Larry Fink (Blackrock) and other executives think so and have published a set of "Commonsense Principles of Corporate Governance" for public companies. [read post]